Nevro Corp (NVRO)
$4.31 -$0.06 (-1.50%) 4:38 PM 12/11/24
NYSE | $USD | Medical DevicesStock Data
-
Market Cap
$157.01M -
Day's Range
$4.14 - $4.35 -
Volume
420,455 -
52 Week Low / High
$3.95 - $22.64 -
PE Ratio
- -
PEG Ratio
-3.13 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 0
- Strong Buy
- 0
- Buy
- 11
- Hold
- 3
- Sell
- 1
- Strong Sell
- $25.57
- Target Price
Company News
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 — Oct 10th, 2024
REDWOOD CITY, Calif., Oct. 10, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the third quarter of 2024 after ...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Sep 19th, 2024
REDWOOD CITY, Calif., Sept. 19, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on September 7, 2024, the Compensation Committee of the Company's Board...
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 — Oct 16th, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on October 7, 2024, the Compensation Committee of the Company's Board of...
Similar Stocks
Portfolio
Comprised of 1 portfolios